Your browser doesn't support javascript.
loading
Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins.
Ferdinand, Keith C; Balavoine, Fabrice; Besse, Bruno; Black, Henry R; Desbrandes, Stephanie; Dittrich, Howard C; Nesbitt, Shawna D.
Affiliation
  • Ferdinand KC; Tulane University School of Medicine, New Orleans, LA (K.C.F.).
  • Balavoine F; Quantum Genomics, Paris, France (F.B., B.B., S.D.).
  • Besse B; Quantum Genomics, Paris, France (F.B., B.B., S.D.).
  • Black HR; New York University School of Medicine (H.R.B.).
  • Desbrandes S; Quantum Genomics, Paris, France (F.B., B.B., S.D.).
  • Dittrich HC; Imager Consulting, Coronado, CA (H.C.D.).
  • Nesbitt SD; University of Texas Southwestern Medical Center, Dallas (S.D.N.).
Circulation ; 140(2): 138-146, 2019 07 09.
Article in En | MEDLINE | ID: mdl-31014072
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glutamyl Aminopeptidase / Enzyme Inhibitors / Overweight / Hypertension Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2019 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glutamyl Aminopeptidase / Enzyme Inhibitors / Overweight / Hypertension Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Circulation Year: 2019 Document type: Article Country of publication: United States